Skip to content

Roger D. Klein, MD JD

Articles, Opinions, Social Media

Menu
  • About
  • Academic Publications
  • Contact
  • Invited Presentations and Panels
  • Media Appearances
  • Op-Eds
  • Public Comments to Federal Agencies
Menu

“Medicare’s New National Coverage Determination for Next Generation Sequencing: What Does it Mean for Diagnostic Laboratories?”

Posted on April 12, 2018April 24, 2018 by admin

I appreciated the opportunity to present the talk “Medicare’s New National Coverage Determination for Next Generation Sequencing: What Does it Mean for Diagnostic Laboratories?” at Labroots’ Molecular Diagnostics 2018 Virtual Event this week.  Registration is free. Webinar sessions will be available online for 12 months. https://www.labroots.com/virtual-event/molecular-diagnostics-2018

Follow me on Twitter

My Tweets

Sign-up for Site Updates

Sign up for site updates
© 2025 Roger D. Klein, MD JD | Powered by Superbs Personal Blog theme